Nemera

With our extensive experience in intranasal delivery, we offer reliable, easy to use and safe nasal vaccine solutions*. The concept device is constituted with a nozzle, a dose divider, and a luer lock syringe. It contains two-doses, allowing vaccine delivery for each nostril.

Our portfolio of disposable pens includes variable and fixed dose devices for automatic and manual drug administration, combining modern design with high intuitiveness of use for multidose therapies. Nemera offers three disposable pen injector development platforms with wide customization and drug capabil...

Implants are fragile and insertion into the body requires caution. Nemera developed a portfolio of devices to deliver implants with integrated needlestick protection. As implants can vary a lot, we support your projects and explore design attributes that will increase the user experience such as improved h...

Ergonomic, market-proven reusable pen injectors Our spring-assisted reusable pens lower the force necessary to administer the dose for patient’s ease-of-use. Thanks to its ergonomic design, patients can easily reach the trigger button for an enhanced injection experience. This platform offers a high range ...

Safe'n'Spray: the smart electronic concept device with locking features Some drugs such as strong painkillers called opioids (e.g. Fentanyl) can cause respiratory depression in case of overdose, and can be fatal. That’s why patients must rely on a device with locking and child-resistant features for multid...

Sof’Bag®+, the airless solution for your sensitive formulations Sof’Bag®+ is an airless pouch-in-bottle technology allowing the formulation to be dispensed out of a collapsing pouch encased inside a rigid bottle upon pump actuation. Each actuation delivers a precise metered dose of formulation, which is di...

Symbioze: fostering patient adherence with high-volume, multiple-use wearable. Symbioze is specifically tailored to administer complex drugs, such as biologic therapies, thanks to a highly engineered, reliable drug delivery system. It is suitable for large volumes such as 20ml and beyond, while preserving...

UniSpray: ideal systemic delivery for emergency lifesaving and crisis treatments UniSpray is a unidose system concept under development, designed to be robust and compatible with existing marketed primary container. Through usability analysis and Freedom to Operate assessment, we assure reliability and reg...

Novelia®: Nemera’s preservative-free multidose eyedropper, is used across 4 continents
Preservatives have been shown to be harmful to the eye and can lead patients to discontinue or skip treatment to avoid irritation and discomfort.
The new preservative-free multidose ophthalmic packaging Nove...

Nemera offers an extensive range of metered pumps and valves, compatible with a wide choice of actuators in different shapes and fitments for nasal, buccal and auricular delivery.
Here our different pumps:
SP27 - SP 37: Quality systems for unregulated markets

SP270+ - SP370+: Qual...

Unispray is a ready-to-use primeless nasal device with accurate single-metered liquid dose delivery. It offers one-handed activation with 360° functionality to face emergency and crisis.
Thanks to its ergonomic design, it is intuitive and easy-to-use.

Safe’n’Spray, the new smart nasal spray with locking features, dramatically improves the existing way of administrating specific pain treatments, avoiding the risk of overdosing.

More modern, our new brand identity truly embodies who we are, how we partner with our customers and ultimately the value we bring to millions of patients across the world through our drug delivery device solutions.

The Innovation in Connectivity Roundtable originally aired as part of Pharmapack Europe 2021 Part 1 of this session includes three presentations: Patient Journey Driven Considerations for Integrating Digital Health for Combination Products The importance of utilizing applied ethnography and other primary research methods to understand the patient journey as the foundation for integrating digital health into a device/combination product development initiative. Considering patient needs in the context of a larger ecosystem including providers, payers, and regulators to develop a robust plan with respect to connectivity and digital health. Examples of how this understanding is applied across the combination product development journey through organic development, utilization of platform devices, or as a lifecycle management enchantments while optimizing the user experience resulting in safe, effective, and differentiated combination products. Mark Tunkel, Global Category Director for Insight Innovation, Nemera Electronic Product Information: A Case Study on Medicine Labelling for the Visually Impaired The Electronic Product Information Initiative for Medicines (ePI) aim to ease the accessibility of product information to everyone, including visually impaired patients. The GS1 Digital Link aim to provide a single barcode for identification, brand protection, and access to product information for patients. Our lecture will illustrate how the existing Datamatrix on packaging could be leveraged, today, by everyone, including visually impaired users, to access a tailored and relevant information. Laurent Tonnelier, CEO, mobiLead - xTag Lise Wagner, Accessibility Specialist and User Expert, OKEENEA Traceability of Medicines: from Finished Product to Unit Dose Delivery Challenges for B2B Supply Chain stakeholders Regulations: a global overview What about B2C Nathalie Wardé, CEO & Founder, D4P pharma Join the above speakers and moderator Lionel Jeannin, Group Head Oral Packaging & Delivery Systems, Novartis Pharma AG for the live panel discussion that followed in the Innovation in Connectivity Roundtable pt. 2